Zimmer Biomet CFO Resigns; Internal Controller Appointed Interim CFO
Summary
Zimmer Biomet's CFO, Suketu Upadhyay, is resigning, with Paul Stellato, the current Controller, stepping in as interim CFO, ensuring continuity during the search for a permanent replacement.
Key Events
-
Chief Financial Officer Resigns
Suketu Upadhyay informed the company of his intention to resign as CFO and Executive Vice President, effective April 28, 2026, to pursue a new professional opportunity. The company stated his departure is not due to any disagreements.
-
Interim CFO Appointed
Paul Stellato, Vice President, Controller, and Chief Accounting Officer, has been appointed interim Chief Financial Officer, effective upon Mr. Upadhyay's departure. He will also continue in his current role.
-
Interim CFO Compensation Details
Mr. Stellato's interim compensation includes an annual base salary of $550,000, a target annual bonus of 70% of base salary, and incremental equity awards totaling approximately $850,000 in grant date fair value.
Analysis
Zimmer Biomet announced the departure of its Chief Financial Officer, Suketu Upadhyay, who is leaving for a new professional opportunity. The company clarified that his resignation is not due to any disagreements regarding financial reporting or operations, which helps mitigate potential concerns. Paul Stellato, the current Vice President, Controller, and Chief Accounting Officer, has been appointed interim CFO, providing continuity during the search for a permanent successor. This transition introduces some uncertainty in leadership but is managed by an internal, experienced appointment.
At the time of this filing, ZBH was trading at $93.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $17.9B. The 52-week trading range was $84.59 to $108.29. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.